Daiichi Sankyo Co., Ltd.
(Tokyo Stock Exchange : DSKYF)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
HZNPHorizon Therapeutics Plc -1.55%57.856.5%$170.93m
CTLTCatalent, Inc. 2.28%77.962.1%$129.98m
VRXValeant Pharmaceuticals International, Inc. -2.17%17.1714.1%$101.03m
JAZZJazz Pharmaceuticals Plc -2.33%105.032.4%$94.65m
BHCBausch Health Cos., Inc. -2.22%17.160.0%$71.80m
UTHRUnited Therapeutics Corp. -0.40%117.3114.3%$69.25m
ICPTIntercept Pharmaceuticals, Inc. -0.16%43.9816.8%$60.85m
PCRXPacira Biosciences, Inc. 1.82%57.5710.3%$52.86m
AXSMAxsome Therapeutics, Inc. -4.08%82.341.9%$51.79m
ZGNXZogenix, Inc. 0.32%28.377.5%$49.56m
PRGOPerrigo Co. Plc -1.95%53.866.8%$47.20m
MYOKMyoKardia, Inc. -2.69%92.731.8%$45.70m
ARGXargenx SE -0.12%251.080.0%$42.41m
GWPHGW Pharmaceuticals Plc -0.80%127.976.2%$38.99m
ICLRICON plc 1.44%173.864.3%$37.29m

Company Profile

Daiichi Sankyo Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceuticals. Its products include drugs for the field of oncology such as Trastuzumab deruxtecan, Anti-HER3-ADC, Quizartinib, Milademetan, Valemetostat, Pexidartinib, Edoxaban, Prasugel, and Microgabalin. The company was founded on September 28, 2005 and is headquartered in Tokyo, Japan.